Hemophilia
📧 Sign up to get email alerts when something new happens for Hemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B [Phase 3]
Phase 3 study of recombinant Factor IX Fc fusion protein (rFIXFc) in participants with severe Hemophilia B completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings [Phase 4]
Phase 4 study evaluating the safety of switching Hemophilia A patients to ReFacto AF in usual care; the trial was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A [Phase 3]
Phase 3 trial evaluating recombinant Factor VIII Fc fusion protein (rFVIIIFc) in previously treated patients with severe Hemophilia A comple…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors [Phase 1]
A Phase 1 study of the Factor VIIa variant BAY86-6150 (B0189) in adults with Hemophilia A or Hemophilia B (with or without inhibitors) has c…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Kogenate FS Regulatory Post-Marketing Surveillance
A post-marketing surveillance trial for Bayer's Kogenate FS focusing on Hemophilia A has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects [Phase 1]
A Phase 1 study evaluating safety and pharmacokinetics of two investigational products, NNC 0128-0000-2011 and NNC 0128-0000-2021, in health…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy [Phase 4]
This Phase 4 clinical trial evaluated the impact of custom-made orthoses as conservative treatment for haemophilic ankle arthropathy, and th…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A [Phase 3]
Phase 3 clinical trial update evaluating safety, efficacy, and pharmacokinetics of GreenGene F in previously treated patients with severe He…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Individualized Prophylaxis for Severe Hemophilia A Children [NA]
This entry reports a clinical trial on individualized prophylaxis for children with severe Hemophilia A, sponsored by Beijing Children's Hos…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia [Phase 1]
A Phase 1 clinical trial at Cairo University evaluating allogeneic bone marrow–derived mesenchymal stem cell therapy for hemophilia.
-
CLINICAL_TRIALS withdrawal · 2014-03-26Clinical Trial Update: Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects [Phase 1]
A Phase 1 bioequivalence trial comparing Eptacog Alfa A 6 mg to NovoSeven in healthy male subjects has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Hemophilia Inhibitor Genetics Study (HIGS)
The Hemophilia Inhibitor Genetics Study (HIGS) clinical trial has completed, per sponsor Skane University Hospital.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor [Phase 3]
Phase 3 trial comparing prophylactic versus on-demand Feiba NF in Hemophilia A or B patients with high-titer inhibitors; study completed wit…
-
FDA approval · 2014-02-28FDA Approved: DDAVP — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA approved a supplemental application for DDAVP (desmopressin acetate) filed by Ferring Pharmaceuticals Inc. The action updates the pr…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A [Phase 3]
Phase 3 trial comparing prophylaxis versus on-demand therapy using a new full-length recombinant factor VIII in patients with severe Hemophi…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs) [Phase 3]
Phase 3 trial update evaluating long-term efficacy and safety of human-cl rhFVIII in previously treated patients with severe Hemophilia A; c…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS
A completed Bayer-sponsored trial assesses the efficacy and long-term safety of KOGENATE for Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A [Phase 2]
Phase 2 clinical trial evaluating pharmacokinetics, efficacy, safety, and immunogenicity of a recombinant factor VIII in patients with sever…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222 [Phase 1]
A Phase 1 pharmacokinetic study compared two strengths of BAY14-2222 in Hemophilia A and has completed.
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A [Phase 3]
This entry describes a Phase 3 safety and efficacy extension study of GreenGene F in previously treated patients with severe Hemophilia A. T…
-
CLINICAL_TRIALS research · 2013-12-23Clinical Trial Update: Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors
This clinical trial update describes a case-control pilot study assessing the immune-modulating effect of FEIBA in patients with severe Hemo…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Health Related Quality of Life of Youth and Young Adults With Hemophilia A
This clinical trial update reports on health-related quality of life outcomes in youth and young adults with Hemophilia A.
-
EMA guidance · 2013-12-06PRAC considers benefits of Kogenate Bayer/Helixate NexGen outweigh risks in previously untreated patients
PRAC concluded that the benefits of Kogenate Bayer/Helixate NexGen outweigh the risks in previously untreated patients, informing risk-benef…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients [Phase 3]
Phase 3 trial update for BAX 326 (recombinant factor IX) in Hemophilia B, reporting on pharmacokinetics, efficacy, and safety with completed…
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A [Phase 3]
Phase 3 trial evaluating the efficacy and safety of a new full-length recombinant human Factor VIII for Hemophilia A has been completed with…